{"id":"https://openalex.org/A5116078328","orcid":"https://orcid.org/0000-0002-3297-1608","observed_orcids":["https://orcid.org/0000-0002-3297-1608"],"display_name":"\u0411. \u0410. \u0411\u0430\u043a\u0438\u0440\u043e\u0432","raw_author_names":["B. A. Bakirov","\u0411. \u0410. \u0411\u0430\u043a\u0438\u0440\u043e\u0432"],"full_name":"\u0411. \u0410. \u0411\u0430\u043a\u0438\u0440\u043e\u0432","works_count":6,"cited_by_count":2,"summary_stats":{"2yr_mean_citedness":0.6666666666666666,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5116078328","orcid":"https://orcid.org/0000-0002-3297-1608","observed_orcids":["https://orcid.org/0000-0002-3297-1608"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210120901","ror":"https://ror.org/02w1g0f30","display_name":"Bashkir State Medical University","country_code":"RU","type":"education","lineage":["https://openalex.org/I4210120901"]},"years":[2026]}],"last_known_institutions":[{"id":"https://openalex.org/I4210120901","ror":"https://ror.org/02w1g0f30","display_name":"Bashkir State Medical University","country_code":"RU","type":"education","lineage":["https://openalex.org/I4210120901"]}],"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","count":2,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","count":2,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","count":2,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10066","display_name":"Gut microbiota and health","count":1,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10254","display_name":"Innovations in Medical Education","count":1,"subfield":{"id":"https://openalex.org/subfields/3304","display_name":"Education"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","value":2.66e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12599","display_name":"Retinal and Optic Conditions","value":1.99e-05,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","value":1.91e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","value":1.17e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13467","display_name":"Drug-Induced Ocular Toxicity","value":1.1e-05,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.9355999827384949},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.7559000253677368},{"id":"143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","score":0.4659999907016754},{"id":"168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","score":0.3849000036716461},{"id":"41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","score":0.2649422585964203}],"counts_by_year":[{"year":2023,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2024,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2026,"works_count":2,"oa_works_count":2,"cited_by_count":2}],"display_name_alternatives":["B. A. Bakirov","\u0411. \u0410. \u0411\u0430\u043a\u0438\u0440\u043e\u0432"],"block_key":"b bakirov","works_api_url":"https://api.openalex.org/works?filter=author.id:A5116078328","awards_count":0,"updated_date":"2026-11-04T11:47:51","created_date":"2024-06-20T00:00:00"}